Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.96 USD | -0.34% | -5.73% | +67.23% |
May. 14 | Taysha Gene Therapies Q1 Net Loss Narrows, Revenue Declines -- Shares Down After Hours | MT |
May. 14 | Transcript : Taysha Gene Therapies, Inc., Q1 2024 Earnings Call, May 14, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+67.23% | 554M | |
+64.92% | 62.86B | |
-1.85% | 41.38B | |
+45.77% | 40.38B | |
-8.93% | 27.64B | |
+13.05% | 26.46B | |
-21.96% | 18.9B | |
+4.21% | 12.67B | |
+25.74% | 12.27B | |
+27.42% | 12.07B |
- Stock Market
- Equities
- TSHA Stock
- News Taysha Gene Therapies, Inc.
- Needham Adjusts Taysha Gene Therapies Price Target to $7 From $5, Maintains Buy Rating